1994The Chinese Journal of Clinical PharmacologyRequires access

STUDY ON PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OFDOMESTIC CONTROLLED-RELEASE THEOPHYLLINE TABLETAFTER SINGLE AND MULTIPLE DOES ORAL

Mo Hong

Open publisher page 0 citations

Abstract

HPLC method was used to study the pharmacokinetics and relative bioavailability ofdomestic controlled - release theophylline tablet (DCRTT) and imported controlled - release theophylline capsule (theovent) in 11 healthy volunteers, Our result indicated that the pharmacokinetic parameters for DCRTTwere: T1/2Ke= 14. 07 ± 1.32 h, T1/2Ka= 1.26 ± 0.14 h, V / F(c) =46.2 ± 9.25 1, Cmax = 4. 21 ± 0. 53 mg/l, AUC = 108.6±17. 97 mg· h· 1-1, Relative bioavailability was 0. 844 compared with theovent and the execretion rate of parent drug in urine was 9. 7% within 24 h; for the theovent were: T1/2Ke=9. 89 ± 0.62h, T1/2Ka= 0.52±0.08 h, V / F(c) =27.8± 6.71, Cmax = 7.64±1.21 mg/l, AUC = 128.7 ±25.80 mg · h-1·L-1.The steady - state pharmacokinetics of DCRTT and theovent were investigated in 9 asthma or COPD patients. The result showed that flutuation rate of DCRTT in range of effecting concentration was smaller than that of theovent(P0. 5) .

About this research paper

What this paper is about

HPLC method was used to study the pharmacokinetics and relative bioavailability ofdomestic controlled - release theophylline tablet (DCRTT) and imported controlled - release theophylline capsule (theovent) in 11 healthy volunteers, Our result indicated that the pharmacokinetic parameters for DCRTTwere: T1/2Ke= 14. 07 ± 1.32 h, T1/2Ka= 1.26 ± 0.14 h, V / F(c) =46.2 ± 9.25 1, Cmax = 4. 21 ± 0. 53 mg/l, AUC = 108.6±17. 97 mg· h· 1-1, Relative bioavailability was 0. 844 compared with theovent and the execretion rate of parent drug in urine was 9. 7% within 24 h; for the theovent were: T1/2Ke=9. 89 ± 0.62h, T1/2Ka= 0.52±0.08 h, V / F(c) =27.8± 6.71, Cmax = 7.64±1.21 mg/l, AUC = 128.7 ±25.80 mg · h-1·L-1.The steady - state pharmacokinetics of DCRTT and theovent were investigated in 9 asthma or COPD patients. The result showed that flutuation rate of DCRTT in range of effecting concentration was smaller than that of theovent(P0. 5) .

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

HPLC method was used to study the pharmacokinetics and relative bioavailability ofdomestic controlled - release theophylline tablet (DCRTT) and imported controlled - release theophylline capsule (theovent) in 11 healthy volunteers, Our result indicated that the pharmacokinetic parameters for DCRTTwere: T1/2Ke= 14. 07 ± 1.32 h, T1/2Ka= 1.26 ± 0.14 h, V / F(c) =46.2 ± 9.25 1, Cmax = 4. 21 ± 0. 53 mg/l, AUC = 108.6±17. 97 mg· h· 1-1, Relative bioavailability was 0. 844 compared with theovent and the execretion rate of parent drug in urine was 9. 7% within 24 h; for the theovent were: T1/2Ke=9. 89 ± 0.62h, T1/2Ka= 0.52±0.08 h, V / F(c) =27.8± 6.71, Cmax = 7.64±1.21 mg/l, AUC = 128.7 ±25.80 mg · h-1·L-1.The steady - state pharmacokinetics of DCRTT and theovent were investigated in 9 asthma or COPD patients. The result showed that flutuation rate of DCRTT in range of effecting concentration was smaller than that of theovent(P0. 5) .

Key concepts: Theophylline, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Bronchodilator, Capsule, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
STUDY ON PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OFDOMESTIC CONTROLLED-RELEASE THEOPHYLLINE TABLETAFTER SINGLE AND MULTIPLE DOES ORAL — Research Paper | ScholarLens